You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Medication utilization evaluation of prasugrel
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-HPS-035
- By: RAY, Chin (Chang Gung Memorial Hospital, Linkou, Taiwan, Department of Pharmacy, China Taiwan)
- Co-author(s): Chin-Ying Ray: Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taiwan , Taoyuan City , Taiwan, Province of China
Shin-Tarng Deng: Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taiwan , Taoyuan City , Taiwan, Province of China
Szu-Hsuan Wang: Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taiwan , Taoyuan City , Taiwan, Province of China
Tzu-Cheng Tsai: Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taiwan , Taoyuan City , Taiwan, Province of China - Abstract:
Background
Current guidelines suggest dual antiplatelet therapy with aspirin and prasugrel or ticagrelor is the treatment of choice in patients with acute coronary syndromes (ACS) and for those undergoing percutaneous coronary interventions (PCI). However, prasugrel for ACS patients who do not perform PCI or stent, the mortality control is.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026